Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 we » _ we (Expand Search), 5 wt (Expand Search), 5 w (Expand Search)
Showing 201 - 220 results of 42,533 for search '(( 5 we decrease ) OR ( 50 ((((mg decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 0.86s Refine Results
  1. 201
    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 <sup>a</sup> indicates ≥1.50 SD (17.9) from the mean (32.9), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 <sup>a</sup> indicates ≥1.50 SD (17.9) from the mean (32.9... by Luke R. Cavanah (19022435)

    Published 2025
    Save to List
    Saved in:
  2. 202
    Large state-wide variation (11.1-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2015 <sup>a</sup> indicates ≥1.50 SD (20.2) from the mean (36.4), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (11.1-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2015 <sup>a</sup> indicates ≥1.50 SD (20.2) from the mean (36.... by Luke R. Cavanah (19022435)

    Published 2025
    Save to List
    Saved in:
  3. 203
    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 <sup>a</sup> indicates ≥1.50 SD (18.0) from the mean (33.1), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 <sup>a</sup> indicates ≥1.50 SD (18.0) from the mean (33.1... by Luke R. Cavanah (19022435)

    Published 2025
    Save to List
    Saved in:
  4. 204
    Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 <sup>a</sup> indicates ≥1.50 SD (16.8) from the mean (31.0), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 <sup>a</sup> indicates ≥1.50 SD (16.8) from the mean (31.0... by Luke R. Cavanah (19022435)

    Published 2025
    Save to List
    Saved in:
  5. 205
    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 <sup>a</sup> indicates ≥1.50 SD (16.0) from the mean (29.9), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 <sup>a</sup> indicates ≥1.50 SD (16.0) from the mean (29.9... by Luke R. Cavanah (19022435)

    Published 2025
    Save to List
    Saved in:
  6. 206
    Large state-wide variation (10.2-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2016 <sup>a</sup> indicates ≥1.50 SD (19.2) from the mean (34.8), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (10.2-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2016 <sup>a</sup> indicates ≥1.50 SD (19.2) from the mean (34.... by Luke R. Cavanah (19022435)

    Published 2025
    Save to List
    Saved in:
  7. 207
    Association between CVR components<sup>b'*'</sup> and depressive status (BDI-II ≥18) in the PREDIMED-PLUS trial.

    Association between CVR components<sup>b'*'</sup> and depressive status (BDI-II ≥18) in the PREDIMED-PLUS trial. by Sandra Martín-Peláez (11353470)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 208
    Baseline characteristics of the study participants.

    Baseline characteristics of the study participants. by Sandra Martín-Peláez (11353470)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 209
    Flow chart for the analysis of cardiovascular risk and depression in the PREDIMED-PLUS trial.

    Flow chart for the analysis of cardiovascular risk and depression in the PREDIMED-PLUS trial. by Sandra Martín-Peláez (11353470)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 210
    Lethal time (mean LT<sub>50</sub> and LT<sub>90</sub> with 95% confidence limits) for aphid populations from different agroecological zones exposed to six entomopathogenic fungal isolates at a concentration of 3.2×10<sup>6</sup>.

    Lethal time (mean LT<sub>50</sub> and LT<sub>90</sub> with 95% confidence limits) for aphid populations from different agroecological zones exposed to six entomopathogenic fungal i... by Aime Cheoh Enoh (20141758)

    Published 2024
    Save to List
    Saved in:
  11. 211
    Image_5_Sleeve gastrectomy decreases high-fat diet induced colonic pro-inflammatory status through the gut microbiota alterations.tiff

    Image_5_Sleeve gastrectomy decreases high-fat diet induced colonic pro-inflammatory status through the gut microbiota alterations.tiff by Chong Cao (3336390)

    Published 2023
    Save to List
    Saved in:
  12. 212
    Cellular uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA.

    Cellular uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA. by Takuro Iwao (14636741)

    Published 2023
    Save to List
    Saved in:
  13. 213
    Cytotoxicity (as of %Control) IC<sub>50</sub> value (mean ±SD in µM) of the tested compounds vs. positive controls Cisplatin and doxorubicin against other malignancy’ cell lines adherent monolayers.

    Cytotoxicity (as of %Control) IC<sub>50</sub> value (mean ±SD in µM) of the tested compounds vs. positive controls Cisplatin and doxorubicin against other malignancy’ cell lines ad... by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Save to List
    Saved in:
  14. 214
    Flowchart of patients.

    Flowchart of patients. by Seydou Goro (17847203)

    Published 2024
    “…Mortality at 30 days was 3.6% and we found that the mortality decreases with increasing of the hospital activity. …”
    Save to List
    Saved in:
  15. 215
    BIC of models tested throughout model building.

    BIC of models tested throughout model building. by Guillaume Lingas (9955528)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  16. 216
    Pharmacokinetic models and concentrations predictions of treatments considered.

    Pharmacokinetic models and concentrations predictions of treatments considered. by Guillaume Lingas (9955528)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  17. 217
    Mutagenesis model simulations.

    Mutagenesis model simulations. by Guillaume Lingas (9955528)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  18. 218
    Reduction of thymic weight and size in rats administered cocaine.

    Reduction of thymic weight and size in rats administered cocaine. by Kana Unuma (283272)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 219
    Effect of cilostazol on liver caspase-3 in TAA-induced fibrosis in rats.

    Effect of cilostazol on liver caspase-3 in TAA-induced fibrosis in rats. by Sally A. El Awdan (710176)

    Published 2019
    Save to List
    Saved in:
  20. 220
    Effect of cilostazol on liver content of cAMP in TAA-induced fibrosis in rats.

    Effect of cilostazol on liver content of cAMP in TAA-induced fibrosis in rats. by Sally A. El Awdan (710176)

    Published 2019
    Save to List
    Saved in:

Search Tools: